RetinalGenix Technologies Inc. RTGN
$3.99
-$0.01-0.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.52% | -8.73% | -40.63% | -31.41% | -32.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.11% | -12.00% | -43.84% | -33.14% | -31.97% |
| Operating Income | 24.11% | 12.00% | 43.84% | 33.14% | 31.97% |
| Income Before Tax | 23.95% | 11.96% | 43.79% | 33.11% | 31.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.95% | 11.96% | 43.79% | 33.11% | 31.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.95% | 11.96% | 43.79% | 33.11% | 31.94% |
| EBIT | 24.11% | 12.00% | 43.84% | 33.14% | 31.97% |
| EBITDA | 24.10% | 11.99% | 43.84% | 33.15% | 31.98% |
| EPS Basic | 25.86% | 14.22% | 45.89% | 35.42% | 34.18% |
| Normalized Basic EPS | 25.80% | 14.17% | 45.90% | 35.39% | 34.17% |
| EPS Diluted | 25.86% | 14.22% | 45.89% | 35.42% | 34.18% |
| Normalized Diluted EPS | 25.80% | 14.17% | 45.90% | 35.39% | 34.17% |
| Average Basic Shares Outstanding | 2.49% | 2.48% | 3.37% | 3.49% | 3.65% |
| Average Diluted Shares Outstanding | 2.49% | 2.48% | 3.37% | 3.49% | 3.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |